Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochemical Pharmacology

• Publication date

  2004-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BCP.2003.09.006PMID 14698043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice

  2001cited by this paper
• Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

  2001cited by this paper
• CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products*

  2001cited by this paper
• Cytoskeletal Effects of Rho-Like Small Guanine Nucleotide–Binding Proteins in the Vascular System

  2001cited by this paper
• ERRATA

  2001cited by this paper
• Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation.

  2001cited by this paper
• RhoA is required for monocyte tail retraction during transendothelial migration

  2001cited by this paper
• Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system.

  2001cited by this paper
• Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

  2000cited by this paper
• The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

  2000cited by this paper
• Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

  2000cited by this paper
• Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient mice

  2000cited by this paper
• CD36 and atherosclerosis

  2000cited by this paper
• Suppression of Endothelial Nitric Oxide Production After Withdrawal of Statin Treatment Is Mediated by Negative Feedback Regulation of Rho GTPase Gene Transcription

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

  2000cited by this paper
• Involvement of Rho GTPases in the Transcriptional Inhibition of Preproendothelin-1 Gene Expression by Simvastatin in Vascular Endothelial Cells

  2000cited by this paper
• Monocyte Adhesion and Spreading on Human Endothelial Cells Is Dependent on Rho-regulated Receptor Clustering

  1999cited by this paper
• Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages.

  1999cited by this paper
• CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta.

  1999cited by this paper
• Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

  1999cited by this paper
• Integrin-dependent Leukocyte Adhesion Involves Geranylgeranylated Protein(s)*

  1999cited by this paper
• The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin.

  1999cited by this paper
• Muscle-specific Overexpression of FAT/CD36 Enhances Fatty Acid Oxidation by Contracting Muscle, Reduces Plasma Triglycerides and Fatty Acids, and Increases Plasma Glucose and Insulin*

  1999cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

  1998cited by this paper
• Rho GTPases*

  1998cited by this paper
• PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL

  1998cited by this paper
• Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.

  1998cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins.

  1998cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• Post-transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase*

  1998cited by this paper
• PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

  1998cited by this paper
• Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.

  1998cited by this paper
• Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton.

  1997cited by this paper
• Bacterial toxins that target Rho proteins.

  1997cited by this paper
• The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

  1997cited by this paper
• Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36*

  1997cited by this paper
• Role of Rho Protein in Lovastatin-Induced Breakdown of Actin Cytoskeleton 1

  1997cited by this paper
• Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators.

  1996cited by this paper
• Rho is a negative regulator of human monocyte spreading.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells.

  1996cited by this paper
• Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages.

  1996cited by this paper
• Protein prenylation: molecular mechanisms and functional consequences.

  1996cited by this paper
• Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation.

  1996cited by this paper
• Structural and Functional Characterization of the Human CD36 Gene Promoter

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Images in clinical medicine: corticosteroid osteonecrosis.

  1995cited by this paper
• Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

  1992cited by this paper
• Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells.

  1991cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper

• Human CD36: Gene Regulation, Protein Function, and Its Role in Atherosclerosis Pathogenesis

  2025cites this paper
• Statin-regulated phagocytosis and efferocytosis in physiological and pathological conditions.

  2022cites this paper
• The role of anti-proliferative effects of atorvastatin on uterine fibroids: findings from a clinical study

  2021cites this paper
• Geranylgeraniol Suppresses the Expression of IRAK1 and TRAF6 to Inhibit NFκB Activation in Lipopolysaccharide-Induced Inflammatory Responses in Human Macrophage-Like Cells

  2019cites this paper
• NUTRACEUTICALS: A BETTER ALTERNATIVE TO STATINS IN THE FIGHT AGAINST ATHEROSCLEROSIS - A REVIEW

  2019cites this paper
• Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment

  2019cites this paper
• Hyaluronan derived nanoparticle for simvastatin delivery: evaluation of simvastatin induced myotoxicity in tissue engineered skeletal muscle.

  2019cites this paper
• The adhesion and migration of microglia to β-amyloid (Aβ) is decreased with aging and inhibited by Nogo/NgR pathway

  2018cites this paper
• Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals

  2017cites this paper
• The use of topical subgingival application of simvastatin gel in treatment of peri implant mucisitis : A pilot study

  2017cites this paper
• Mevalonate Metabolism in Immuno-Oncology

  2017cites this paper
• Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.

  2017cites this paper
• Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors

  2014cites this paper
• Breast Density and Breast Cancer Risk: Understanding of Biology and Risk

  2014cites this paper
• Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density.

  2014cites this paper
• Effects of Oxidized Phospholipids on Gene Expression in RAW 264.7 Macrophages: A Microarray Study

  2014cites this paper
• Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.

  2013cites this paper
• Molecular mechanisms of hypolipidemic effects of curcumin

  2013cites this paper
• CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.

  2012cites this paper
• Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)

  2012cites this paper
• Régulation du métabolisme et du transport des lipides dans les macrophages : potentiel anti-athérosclérotique des ligands du CD36

  2012cites this paper
• Highly Upregulated Expression of CD36 and MSR1 in Circulating Monocytes of Patients with Acute Coronary Syndromes

  2012cites this paper
• Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as human scavenger receptor CD36 antagonists.

  2011cites this paper
• Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.

  2011cites this paper
• Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.

  2011cites this paper
• Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

  2010cites this paper
• oxHDL decreases the expression of CD36 on human macrophages through PPARγ and p38 MAP kinase dependent mechanisms

  2010cites this paper
• Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

  2010cites this paper
• Signaling mechanisms for oxidized LDL-induced oxidative stress and the upregulation of plasminogen activator inhibitor-I in vascular cells

  2010cites this paper
• Does fluvastatin favour HCV replication in vivo? A pilot study on HIV–HCV coinfected patients

  2009cites this paper
• Adverse effects of statins - mechanisms and consequences.

  2009cites this paper
• Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes.

  2009cites this paper
• Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP‐1 cells, without decreasing the beneficial effects on cholesterol synthesis

  2009cites this paper
• ВПЛИВ АКТИВАЦІЇ РЕЦЕПТОРІВ PPAR-γ НА ФУНКЦІЮ ЕНДОТЕЛІЮ ЗА ДАНИМИ ПРОБИ ЦЕЛЕРМАЄРА - СОРЕНСЕНА ТА АТЕРОСКЛЕРОТИЧНЕ УРАЖЕННЯ СОННИХ АРТЕРІЙ У ХВОРИХ НА РЕВМАТОЇДНИЙ АРТРИТ З МЕТАБОЛІЧНИМ СИНДРОМОМ

  2009cites this paper
• CD36: A multi‐modal target for acute stroke therapy

  2009cites this paper
• Antigen-Induced Immunomodulation in the Pathogenesis of Atherosclerosis

  2008cites this paper
• Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment.

  2008cites this paper
• Regulación de la expresión y función de las lectinas mieloides dc-sign y lsectin

  2008cites this paper
• CD36 mRNA EXPRESSION IS INCREASED IN CD14+ MONOCYTES OF PATIENTS WITH CORONARY HEART DISEASE

  2008cites this paper
• Statin treatment of adult human glial progenitors induces PPARγ‐mediated oligodendrocytic differentiation

  2008cites this paper
• Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells.

  2008cites this paper
• Molecular Basis of Human CD36 Gene Mutations

  2007cites this paper
• Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

  2007cites this paper
• Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes

  2007cites this paper
• Statins and foam cell formation: impact on LDL oxidation and uptake of oxidized lipoproteins via scavenger receptors.

  2007cites this paper
• El monocito/macrófago como diana terapéutica en la aterosclerosis

  2007cites this paper
• Statins and sepsis: multiple modifications at multiple levels.

  2007cites this paper
• CD36: implications in cardiovascular disease.

  2007cites this paper
• Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells.

  2007cites this paper
• Lovastatin Enhances Clearance of Apoptotic Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary Disease1

  2006cites this paper
• Peroxisome Proliferator‐Activated Receptors: Potential Therapeutic Targets in Lung Disease?

  2006cites this paper
• Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease.

  2006cites this paper
• Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.

  2006cites this paper
• C‐reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease

  2006cites this paper
• Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes.

  2006cites this paper
• Regulation of cGMP-dependent Protein Kinase Expression by Rho and Krüppel-like Transcription Factor-4*

  2006cites this paper
• This information is current as Chronic Obstructive Pulmonary Disease Cells ( Efferocytosis ) with Implications for Lovastatin Enhances Clearance of Apoptotic

  2006cites this paper
• Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures

  2006cites this paper
• Statins downregulate myeloperoxidase gene expression in macrophages.

  2005cites this paper
• Modular Transcriptional Activity Characterizes the Initiation and Progression of Autoimmune Encephalomyelitis1

  2005cites this paper
• Statins and PPARalpha agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatment.

  2005cites this paper
• Lysophosphatidic Acid Inhibits Adipocyte Differentiation via Lysophosphatidic Acid 1 Receptor-dependent Down-regulation of Peroxisome Proliferator-activated Receptor γ2*

  2005cites this paper
• Molecular aspects of atherogenesis: new insights and unsolved questions.

  2005cites this paper
• The role of conjugated linoleic acid in regulating the inflammatory response in human monocytic cells

  2005cites this paper
• Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?

  2005cites this paper
• State of the Arts Peroxisome Proliferator-Activated Receptors: Potential Therapeutic Targets in Lung Disease?

  year unknowncites this paper
• Review Article Peroxisome Proliferator-activated Receptor-γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer

  year unknowncites this paper